Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Sort by: Newest first Oldest first A-Z Z-A

  • Infographic showing the drug targets in rheumatoid arthritis

    Blocking the immune system in rheumatoid arthritis Subscription

    28 APR 2016

    Rheumatoid arthritis is caused by the immune system attacking the body. It afflicts about 1% of people in the UK and is now treated with a variety of biologic drugs that dampen the immune system in different ways

  • Infographic on the breakdown of the total over-the-counter (OTC) market value in Britain in 2015

    Sales of over-the-counter medicines in 2015 by clinical area and top 50 selling brands Subscription

    24 MAR 2016
    Comments (2)

    The over-the-counter products market grew by 2.5% in 2015 to reach £2.55bn, with painkillers accounting for 23.2% of sales, followed by cough and cold remedies (18.7%) and skin treatments (17.8%).

  • Infographic showing the origins of the zika outbreak and its potential threat

    Origins of the Zika outbreak and its potential threat

    26 FEB 2016

    Researchers are working to understand more about the Zika virus — how it is transmitted, its link to microcephaly and Guillain-Barré syndrome and whether a vaccine can be developed.

  • Targeting Hepatitis C: How new treatments work

    Targeting hepatitis C — how new treatments work Subscription

    28 JAN 2016

    There are >185 million people with hepatitis C infection worldwide but new treatments mean that most people with access to therapy can now be cured. 

  • Timeline of the evolution of community pharmacists in the UK from the 1800s to the present

    The evolution of community pharmacists in the UK Subscription

    18 DEC 2015

    Legal cases have helped to shape community pharmacy from its roots in the one-time competitive roles of apothecary and chemist and druggist.

  • A visual history of HIV survival in the UK

    A history of HIV survival in the UK Subscription

    Treatment for HIV has radically improved since the beginning of the epidemic in 1981. HIV-infected people in the UK are now surviving for decades, rather than months or years.

  • Impact and challenges of the flu virus

    Effectiveness of the seasonal flu vaccine and new production methods Subscription

    29 OCT 2015

    Despite a mismatch between the 2014–2015 seasonal flu vaccine and circulating strains, the flu jab is still the best way to protect people in at-risk groups.

  • Oligomers are thought to be more damaging than plaques because they block cell-to-cell signalling at synapses and may also activate immune system cells triggering an attack. Neurofibrillary tangles form within nerve cells, while amyloid plaques build up i

    Closing in on Alzheimer’s disease Subscription

    14 AUG 2015
    Comments (1)

    Knowledge about the neuropathology of Alzheimer’s disease has blossomed over the past few decades, leading to a better understanding of the condition and new ways to attack it.

  • A range of anti-smoking policies and new cessation products has led to reduced rates of smoking in most countries, which will eventually impact on smoking-related deaths.

    A decade of smoking cessation in Europe Subscription

    The continent with the worst smoking habit is gradually giving it up. A range of anti-smoking policies and new cessation products has led to reduced rates of smoking in most countries, which will eventually impact on smoking-related deaths.

  • The 20 largest research-based pharmaceutical companies are active in 75 developing countries in at least one of four areas: research and development; quality management in manufacturing; supply chain management; and pharmacovigilance.

    Targeting disease in the developing world Subscription

    A new report by the Access to Medicine Index finds that pharmaceutical companies influence access to medicines in developing countries through the development of innovative and adapted products, operating equitable pricing strategies and building local capacity.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.